Immunogenicity
Immunogenicity — The ability of a substance to provoke an immune response. A key consideration when designing peptides for repeated administration in research.
What Is Immunogenicity?
Immunogenicity is the ability of a substance to provoke an immune response. For therapeutic peptides, immunogenicity refers to the unwanted formation of anti-drug antibodies (ADAs) that can neutralize the peptide's activity, accelerate its clearance, or cause adverse immune reactions. Managing immunogenicity risk is a critical aspect of peptide drug development.
Factors Affecting Peptide Immunogenicity
- Size: Peptides < 8 residues are generally too small to be immunogenic. Risk increases with size
- Non-natural elements: D-amino acids, PEG, and non-natural modifications may create neo-epitopes
- Sequence homology: Peptides with high sequence identity to human proteins are less immunogenic
- Aggregation: Aggregated peptides are more immunogenic than monomeric forms
- Route: SC injection is more immunogenic than IV
Frequently Asked Questions
What is Immunogenicity?
The ability of a substance to provoke an immune response. A key consideration when designing peptides for repeated administration in research.
Why is Immunogenicity important in peptide research?
Immunogenicity is a fundamental concept in pharmacology as it relates to peptide science. It directly influences experimental design, compound characterization, and the reliability of research outcomes across biochemistry and molecular biology disciplines.
Authority Sources
- Immunogenicity on Wikipedia
- Search Immunogenicity on PubChem (NIH)
- Research articles on ScienceDirect